By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Dna Group (T.R.) Ltd (DNA.TA)

TLV Market Data in ILA, Fundamentals in ILS
ILA 103.00
+ILA 0.60
+0.59%
Last Update: 14 Sept 2025, 12:49
ILA 126.86M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
ILA 66.10 - ILA 121.80
52 Week Range

DNA.TA Stock Price Chart

Explore Dna Group (T.R.) Ltd interactive price chart. Choose custom timeframes to analyze DNA.TA price movements and trends.

DNA.TA Company Profile

Discover essential business fundamentals and corporate details for Dna Group (T.R.) Ltd (DNA.TA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

4 Dec 2007

Employees

13.00

Website

CEO

Erez Navon

Description

Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.) Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.

DNA.TA Financial Timeline

Browse a chronological timeline of Dna Group (T.R.) Ltd corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 30 Jun 2024

EPS came in at ILA 0.08 , while revenue for the quarter reached ILA 76.50K .

Earnings released on 14 May 2024

EPS came in at -ILA 0.02 , while revenue for the quarter reached ILA 76.50K .

Earnings released on 31 Mar 2024

EPS came in at ILA 0.08 , while revenue for the quarter reached ILA 76.50K .

Earnings released on 30 Sept 2023

EPS came in at -ILA 0.02 , while revenue for the quarter reached ILA 76.50K .

Earnings released on 30 Jun 2023

EPS came in at ILA 0.01 , while revenue for the quarter reached ILA 76.50K .

Earnings released on 31 Mar 2023

EPS came in at ILA 0.01 , while revenue for the quarter reached ILA 76.50K .

Earnings released on 31 Dec 2022

EPS came in at -ILA 0.04 , while revenue for the quarter reached ILA 280.00K .

Earnings released on 30 Sept 2022

EPS came in at -ILA 0.04 , while revenue for the quarter reached ILA 280.00K .

Earnings released on 30 Jun 2022

EPS came in at -ILA 0.07 .

Earnings released on 31 Mar 2022

EPS came in at -ILA 0.07 .

Earnings released on 31 Dec 2021

EPS came in at -ILA 0.02 .

Earnings released on 30 Sept 2021

EPS came in at -ILA 0.02 .

Earnings released on 30 Jun 2021

EPS came in at ILA 0.15 .

Earnings released on 31 Mar 2021

EPS came in at ILA 0.15 .

Earnings released on 31 Dec 2020

EPS came in at -ILA 0.16 .

Earnings released on 30 Sept 2020

EPS came in at -ILA 0.16 .

DNA.TA Stock Performance

Access detailed DNA.TA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run